Cannabinoids • Chemistry • Featured

Synthetic Cannabinoids: Medicines, Street Drugs and Converted Hemp Explained

Two scientists in white protective suits and safety goggles examine a test tube of green liquid in a laboratory
Written by Cara Wietstock

“Synthetic cannabinoids” sounds like one thing. It is at least three. The phrase covers a prescription capsule approved by the FDA in 1985, a family of street drugs sold as “K2” and “Spice” that has put people in intensive care, and the delta-8 THC gummies on gas-station counters. They differ in chemistry, in risk and in law, and mixing them up leads to bad decisions in both directions.

Medicines Street drugs Hemp-market products
Examples Dronabinol, nabilone “K2,” “Spice”: JWH-018, AMB-FUBINACA and hundreds more Delta-8 THC, HHC, lab-made THCP
Made from Chemical synthesis Chemical synthesis Varies; delta-8 THC and HHC are usually converted from hemp CBD
Found in the plant? Dronabinol is THC; nabilone is a close relative No In traces, at most
Main concern THC’s usual side effects, at a known dose Severe poisoning, seizures, psychosis, deaths Intoxication, inconsistent doses and labels, by-products and contaminants, accidental use by children

What are synthetic cannabinoids?

Cannabinoids made by chemistry rather than extracted from the cannabis plant. Regulators also use a middle category, “semi-synthetic,” for cannabinoids made by chemically transforming hemp extracts, usually CBD[1]. That gives three groups: natural cannabinoids, extracted from the plant; semi-synthetic ones, converted from plant material; and fully synthetic ones, built from scratch in a laboratory.

This article focuses on three practical categories: approved synthetic medicines, illicit street synthetics and chemically manufactured cannabinoids sold in hemp-market products. Other synthetic compounds exist, including many used only in research. For the cannabinoids the plant makes itself, see our guide to cannabis cannabinoids.

Which synthetic cannabinoids are medicines?

The FDA has approved three synthetic cannabinoid drug products, containing two active ingredients: Marinol and Syndros contain dronabinol, and Cesamet contains nabilone[2].

  • Dronabinol is synthetic delta-9-THC: the same molecule as the THC in cannabis, made to pharmaceutical purity. It was first approved in 1985 and is prescribed for nausea and vomiting from cancer chemotherapy when standard anti-nausea drugs have not worked, and for loss of appetite with weight loss in people with AIDS[3].
  • Nabilone is a synthetic cannabinoid that is chemically similar to THC but not identical to it. It is prescribed for chemotherapy-related nausea and vomiting that has not responded to standard treatments[4].

These approved medicines contain a defined compound, with controlled purity and a specified dose. That does not remove the drug’s risks. Dronabinol’s label lists dizziness, euphoria, paranoid reactions and sleepiness among its common side effects, and warns that it can worsen mania, depression or schizophrenia[3]. Our article on synthetic cannabinoids as medicine looks at the pros and cons, and our guide to THC covers the molecule itself.

What are K2 and Spice?

Street drugs built from research chemicals. Scientists first made synthetic cannabinoids to study the body’s cannabinoid system: some in the early 1980s, others, including JWH-018, in the mid-1990s[5, 6]. “JWH” stands for John W. Huffman, the Clemson University chemist whose team made and published more than 300 such compounds[7].

Others turned them into products. Herbal blends called “Spice” emerged in Europe around 2004, and by late 2008 analysts had identified JWH-018 as one of their active ingredients[6]. By 2021, synthetic cannabinoids were the largest group of new psychoactive substances monitored in Europe, with 209 reported between 2008 and 2020[6]. None of them is a cannabis compound.

Why are street synthetic cannabinoids so dangerous?

They hit the receptor harder. THC is a partial agonist at the CB1 receptor: even at high doses, it switches the receptor only partly on. Many street synthetic cannabinoids are full agonists, and are estimated to be 2 to 100 times more potent than THC[6]. To see why that matters, our article on endocannabinoid signaling in the brain explains what CB1 does.

The harms go well beyond a bad high. Europe’s drug agency reports serious cardiovascular toxicity, including sudden death. Other reported effects include rapid loss of consciousness or coma, slowed breathing, seizures, psychosis and aggressive behaviour[6]. In 2013, the director of the US National Institute on Drug Abuse described severe episodes of anxiety, paranoia and hallucinations, reduced blood supply to the heart, and addiction and withdrawal in regular users[8].

The contents and dose are unpredictable. Users cannot tell which compound they are getting, or how much. Two US outbreaks show what can go wrong:

  • Brooklyn, 2016. In July 2016, 33 people in one New York neighbourhood were poisoned by a product containing AMB-FUBINACA, a compound about 85 times as potent as THC at the CB1 receptor in laboratory tests; 18 were taken to hospital, many in a “zombielike” state[9].
  • Illinois, 2018. From March 2018, patients began arriving at hospitals with unexplained, severe bleeding. Synthetic cannabinoid products had been contaminated with brodifacoum, a long-acting rat poison that stops blood from clotting[10]. The outbreak spread to at least 324 cases of severe poisoning, including eight deaths, in 10 states[6].

Use has also spread among vulnerable groups, including people in prison, where the trade has been linked to more aggression, violence, bullying and debt[6].

Why do new ones keep appearing?

Because manufacturers keep changing chemical structures to evade existing controls. US law now covers named compounds, such as JWH-018, first scheduled in 2011[5]; whole structural classes of “cannabimimetic agents,” added in 2012[11, 12]; and, in some circumstances, close analogues of controlled drugs[12]. Even so, makers slightly modify molecular structures to try to stay ahead[12]. In Europe, 20 of the 23 new synthetic cannabinoids that appeared between June 2021 and July 2022 fell outside a generic ban China introduced in May 2021[13]. Every new compound is, in effect, a new and untested drug.

Where do delta-8 THC, HHC and THCP fit?

In between. They are chemically manufactured cannabinoids, often marketed as hemp products. Delta-8 THC and HHC are typically made by chemically converting CBD extracted from hemp, which is why regulators call them semi-synthetic[1]. Delta-8 THC reached the market first, around 2019; HHC followed in the United States in late 2021 and was first identified in Europe in May 2022[1]. Commercial THCP, which the plant makes only in traces, is generally synthesized in a laboratory, although labels do not always say how; our article on THCP and CBDP covers it.

The risks come from the compounds themselves as well as from how they are made. The FDA warns that delta-8 THC has psychoactive and intoxicating effects similar to those of delta-9 THC, that product formulations, labels and concentrations are inconsistent, and that the chemical conversion can leave potentially harmful by-products, sometimes in uncontrolled or unsanitary settings[14]. The CDC has warned that products labelled as hemp or CBD may contain delta-8 THC without buyers expecting a high[15]. In the first seven months of 2021, US poison centers recorded 660 delta-8 THC exposures; 18% of cases needed hospitalization, and 39% involved people under 18[15]. There are no controlled safety studies of THCP in people, and a 2025 case report described psychosis and a suicide attempt after a single use of a gummy labelled as containing THCP[16].

Federal law is about to change. As summarized by the Congressional Research Service in September 2026, cannabinoids the plant cannot produce naturally fall outside the federal definition of hemp on November 12, 2026, and cannabinoids that occur naturally but are manufactured outside the plant, the category that covers converted delta-8 THC, follow on December 11, 2026[17]. Our explainers on the 2026 hemp redefinition and on THC isomers and derivatives cover the details. State laws vary, and this is not legal advice.

Are synthetic cannabinoids the same as natural ones?

It depends which ones. Dronabinol is chemically identical to the plant’s THC[3]; street synthetics are different molecules that act on the same receptor far more strongly[6]; and delta-8 THC occurs in the plant only in traces. But whether a molecule also occurs in the plant says little about its safety. What matters is its effects, the dose and what else the product contains[14].

Can synthetic cannabinoids turn up in CBD or cannabis products?

Yes. Between late 2017 and January 2018, Utah’s poison control centre identified 52 suspected poisonings linked to products sold as CBD oil. Nine samples tested contained no CBD at all, but a synthetic cannabinoid called 4-cyano CUMYL-BUTINACA; the commonest symptoms were confusion or altered mental status, nausea and vomiting, and seizures or shaking[18]. In Europe, the drug agency has received a growing number of reports since July 2020 of low-THC cannabis products adulterated with synthetic cannabinoids, and of synthetic cannabinoids mis-sold as CBD or THC vape liquids[6].

The chemist Mark Scialdone discusses how this kind of contamination happens in our interview on synthetic cannabinoid contaminants, and our guide to contaminant testing covers what cannabis labs look for.

Can tests detect synthetic cannabinoids?

Specialized tests can, but routine drug screens and cannabis potency panels may miss them. Part of Spice’s early appeal was that standard drug tests did not detect it[8]. Labs can identify synthetic cannabinoids with mass spectrometry, but because new compounds keep appearing, their methods need continual updating[6]. A standard cannabis potency panel reports a fixed list of cannabinoids, so it will not flag a compound that is not on the list. Our articles on mass spectrometry and cannabis testing methods explain how labs work.

What should you do if someone has a bad reaction?

Call emergency services for seizures, chest pain, trouble breathing, unusual bleeding, or if someone cannot be woken. In the United States, Poison Help is free and confidential at 1-800-222-1222. Keep the product and its packaging; it may help doctors work out what was taken.

The short version

“Synthetic cannabinoid” covers three very different things. Dronabinol and nabilone are approved medicines with known doses. K2 and Spice are lab-made drugs that act far more strongly than THC and have caused mass poisonings and deaths. Delta-8 THC, HHC and lab-made THCP are chemically manufactured cannabinoids marketed as hemp products, with intoxicating effects, inconsistent doses and possible by-products. Federal law is changing how they are classified, so check the current rules. Knowing which one you are dealing with is the first step to judging the risk.

References

  1. Ujváry I, Evans-Brown M, Gallegos A, et al. Hexahydrocannabinol (HHC) and related substances. Technical report. European Monitoring Centre for Drugs and Drug Addiction. Luxembourg: Publications Office of the European Union; 2023. doi:10.2810/852912
  2. US Food and Drug Administration. FDA and cannabis: research and drug approval process. Content current as of 24 February 2023.
  3. US Food and Drug Administration. MARINOL (dronabinol) capsules: prescribing information. Revised March 2026.
  4. US Food and Drug Administration. CESAMET (nabilone) capsules: prescribing information. Revised May 2006 (archived copy).
  5. Drug Enforcement Administration. Schedules of controlled substances: temporary placement of five synthetic cannabinoids into Schedule I. Federal Register. 2011;76(40):11075-11078.
  6. European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids in Europe: a review. Technical report. September 2021.
  7. NPR. How the wave of synthetic cannabinoids got started (via WFAE). 4 January 2019.
  8. Volkow ND. Dangerous synthetic drugs. Testimony before the Senate Caucus on International Narcotics Control. 25 September 2013.
  9. Adams AJ, Banister SD, Irizarry L, et al. “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N Engl J Med. Published online 14 December 2016. doi:10.1056/NEJMoa1610300
  10. Kelkar AH, Smith NA, Martial A, et al. An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med. 2018;379:1216-1223. doi:10.1056/NEJMoa1807652
  11. Drug Enforcement Administration. Establishment of drug codes for 26 substances. Federal Register. 2013;78(3):664-666.
  12. Congressional Research Service. Synthetic drugs: overview and issues for Congress. Report R42066. 26 February 2016.
  13. European Union Drugs Agency. From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day. EUDA drugs library.
  14. US Food and Drug Administration. 5 things to know about delta-8 tetrahydrocannabinol (delta-8 THC). Consumer update. Content current as of 4 May 2022.
  15. Centers for Disease Control and Prevention. Increases in availability of cannabis products containing delta-8 THC and reported cases of adverse events. Health Alert Network, CDCHAN-00451. 14 September 2021.
  16. Greer D, Atherton J, Girgis J. Psychosis and suicide attempt following a single use of delta-9-tetrahydrocannabiphorol: a case report. PCN Reports. 2025. doi:10.1002/pcn5.70060
  17. Neuhofer ZT. Changes to the statutory definition of hemp and implications for agricultural policy. Congressional Research Service In Focus IF13136. Updated 28 September 2026.
  18. Horth RZ, Crouch B, Horowitz BZ, et al. Notes from the field: acute poisonings from a synthetic cannabinoid sold as cannabidiol: Utah, 2017-2018. MMWR Morb Mortal Wkly Rep. 2018;67(20):587-588. doi:10.15585/mmwr.mm6720a5

This article is an educational summary of published research and public health reports. It is not medical or legal advice.

Editor’s note: Originally published July 2017 by Cara Wietstock; rewritten and expanded November 2026, merging our 2019 article on synthetic versus natural cannabis (Asia Mayfield) and a 2022 article on synthetic versus plant-derived products. We corrected the account of where synthetic cannabinoids came from (research compounds from the 1980s and 1990s, sold as drugs from the mid-2000s), clarified that US law controls specific compounds, structural classes and close analogues, rather than banning “synthetic cannabinoids” as such, and replaced an uncited symptom table with public health sources.

Last updated: November 2026.

About the author

Cara Wietstock

Cara began working in the retail cannabis industry of San Francisco, CA in 2011 and continued in that sector for years. In 2015 she dedicated herself to writing full-time. Her passion for the written word and deep respect for the healing properties of the plant have brought her to Terpenes and Testing magazine. She now helps keep us on the cutting edge of scientific cannabis discovery as the Editor-in-Chief of the print publication.

Leave a Comment